Graft Versus Host Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Graft Versus Host Disease stocks.

Graft Versus Host Disease Stocks Recent News

Date Stock Title
May 3 OCGN Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results
May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
May 2 EBS Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
May 2 OCGN Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress
May 2 EBS Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 2 EBS Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
May 2 EBS Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
May 2 EBS PRESS DIGEST- Wall Street Journal - May 2
May 2 EBS Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
May 2 EBS Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
May 2 EBS Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
May 1 EBS Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
May 1 EBS Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
May 1 EBS Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M
May 1 EBS Emergent BioSolutions Reports First Quarter 2024 Financial Results
May 1 EBS Emergent BioSolutions to lay off about 300 employees
May 1 EBS UPDATE 2-Emergent BioSolutions to lay off about 300 employees
May 1 EBS Emergent BioSolutions announces reduction of about 300 employees
May 1 EBS Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
Graft Versus Host Disease

Graft-versus-host disease (GvHD) is a syndrome, characterized by inflammation in different organs, with the specificity of epithelial cell apoptosis and crypt drop out. GvHD is commonly associated with bone marrow transplants and stem cell transplants. GvHD also applies to other forms of transplanted tissues such as solid organ transplants.
White blood cells of the donor's immune system which remain within the donated tissue (the graft) recognize the recipient (the host) as foreign (non-self). The white blood cells present within the transplanted tissue then attack the recipient's body's cells, which leads to GvHD. This should not be confused with a transplant rejection, which occurs when the immune system of the transplant recipient rejects the transplanted tissue; GvHD occurs when the donor's immune system's white blood cells reject the recipient. The underlying principle (alloimmunity) is the same, but the details and course may differ. GvHD can also occur after a blood transfusion if the blood products used have not been irradiated or treated with an approved pathogen reduction system.

Browse All Tags